| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.004 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |